---
figid: PMC6591147__CEI-197-36-g003
figlink: /pmc/articles/PMC6591147/figure/cei13290-fig-0003/
number: F3
caption: Mechanisms promoting regulatory T cell (Treg) development and immunosuppression
  in the tumor microenvironment. A, Treg cells are recruited to the tumor through
  chemokine attraction. B, Interaction of Treg cells with antigen‐presenting cells
  (APCs) through cytotoxic T lymphocyte antigen (CTLA)‐4 deprive T effector (Teff)
  cells of co‐stimulatory signals, polarizes dendritic cells (DCs) towards a tolerogenic
  phenotype and induces the expression of indoleamine 2,3‐dioxygenase (IDO), which
  catabolizes metabolites, thereby inducing Teff cell apoptosis. Furthermore, it inhibits
  the reprogramming of Treg cells into Th17 cells by suppressing interleukin (IL)‐6
  secretion and promotes Treg cell lineage stability by inhibiting the transient mammalian
  target of rapamycin complex 1/protein kinase B (mTORC2/Akt) pathway. C, Tumor cells
  express programmed cell death ligand 1 (PD‐L1), which binds programmed cell death
  1 (PD‐1) at the surface of Treg cells. The PD‐1 pathway stabilizes forkhead box
  protein 3 (FoxP3) expression by inhibiting the phosphoinositide‐3‐kinase (PI3K)/Akt
  pathway and synergizes with transforming growth factor (TGF)‐β by diminishing the
  level of Smad3 necessary to promote the conversion of naïve CD4+ T cells into peripheral
  (p)Treg cells, while inducing Teff cell exhaustion.
pmcid: PMC6591147
papertitle: Mechanisms of human FoxP3+ Treg cell development and function in health
  and disease.
reftext: M. Attias, et al. Clin Exp Immunol. 2019 Jul;197(1):36-51.
pmc_ranked_result_index: '74365'
pathway_score: 0.9772398
filename: CEI-197-36-g003.jpg
figtitle: Mechanisms promoting regulatory T cell (Treg) development and immunosuppression
  in the tumor microenvironment
year: '2019'
organisms:
- Homo sapiens
ndex: e9c3b0de-debe-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6591147__CEI-197-36-g003.html
  '@type': Dataset
  description: Mechanisms promoting regulatory T cell (Treg) development and immunosuppression
    in the tumor microenvironment. A, Treg cells are recruited to the tumor through
    chemokine attraction. B, Interaction of Treg cells with antigen‐presenting cells
    (APCs) through cytotoxic T lymphocyte antigen (CTLA)‐4 deprive T effector (Teff)
    cells of co‐stimulatory signals, polarizes dendritic cells (DCs) towards a tolerogenic
    phenotype and induces the expression of indoleamine 2,3‐dioxygenase (IDO), which
    catabolizes metabolites, thereby inducing Teff cell apoptosis. Furthermore, it
    inhibits the reprogramming of Treg cells into Th17 cells by suppressing interleukin
    (IL)‐6 secretion and promotes Treg cell lineage stability by inhibiting the transient
    mammalian target of rapamycin complex 1/protein kinase B (mTORC2/Akt) pathway.
    C, Tumor cells express programmed cell death ligand 1 (PD‐L1), which binds programmed
    cell death 1 (PD‐1) at the surface of Treg cells. The PD‐1 pathway stabilizes
    forkhead box protein 3 (FoxP3) expression by inhibiting the phosphoinositide‐3‐kinase
    (PI3K)/Akt pathway and synergizes with transforming growth factor (TGF)‐β by diminishing
    the level of Smad3 necessary to promote the conversion of naïve CD4+ T cells into
    peripheral (p)Treg cells, while inducing Teff cell exhaustion.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - AKT3
  - AKT1
  - CTLA4
  - CCL22
  - CCR4
  - CD86
  - IL6
  - MTOR
  - RPTOR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - RICTOR
  - MLST8
  - CDK2
  - FOXP3
  - EIF2AK4
  - IDO1
  - PIK3R6
  - PIK3R5
  - PIK3R4
  - PIK3R3
  - SMAD3
  - MAPKAP1
  - PIK3CG
  - TGFB1
  - PDCD1
  - CD274
  - SMAD4
  - TGFB2
  - TGFBR2
  - TGFB3
  - H1H 2
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: CCL22
  symbol: CCL22
  source: hgnc_symbol
  hgnc_symbol: CCL22
  entrez: '6367'
- word: CCR4
  symbol: CCR4
  source: hgnc_symbol
  hgnc_symbol: CCR4
  entrez: '1233'
- word: CD86
  symbol: CD86
  source: hgnc_symbol
  hgnc_symbol: CD86
  entrez: '942'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: FOXP3
  symbol: FOXP3
  source: hgnc_symbol
  hgnc_symbol: FOXP3
  entrez: '50943'
- word: GCN2
  symbol: GCN2
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK4
  entrez: '440275'
- word: IDO
  symbol: IDO
  source: hgnc_prev_symbol
  hgnc_symbol: IDO1
  entrez: '3620'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Smad3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: Smad4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-BRII
  symbol: TGFBR2
  source: hgnc_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
chemicals:
- word: H1H 2
  source: MESH
  identifier: D006859
diseases: []
figid_alias: PMC6591147__F3
redirect_from: /figures/PMC6591147__F3
figtype: Figure
---
